Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation
Date:8/2/2009
w products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or less expensive products or new technology for the production of products, the entry into the market of new competitors, market and customer acceptance and demand for new pharmaceutical products, availability of raw materials, timing and success of product development and launches, dependence on few products generating majority of sales, product liability claims for which the Company may be inadequately insured, and other risks identified in this report and from time to time in our periodic reports and registration statements. These forward-looking statements represent our judgment as of the date of this report. We disclaim, however, any intent or obligation to update our forward-looking statements.
'/>"/>
| SOURCE Caraco Pharmaceutical Laboratories, Ltd. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEO
2. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010
3. Caraco Pharmaceutical Laboratories, Ltd. Announces Filing of Purported Class Action Lawsuits
4. Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation
5. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
6. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
7. Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection
10. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) Tablets
11. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) Tablets
Post Your Comments:
(Date:5/20/2013)... Atlanta, GA (PRWEB) May 20, 2013 Soliant ... Adecco Group, has opened up voting for its fifth annual ... wealth of great nominations this year, Soliant decided to bypass ... 50 entries, but all entries received to be in the ... The voting period begins on May 20 and runs through ...
(Date:5/20/2013)... May 20, 2013 Jointly ... (PolyU) and Sichuan University (Sichuan U), China's ... (IDMR) has recently been officially opened. Both ... Revival and International Disaster Reduction" to conclude ... Lushan 4.20 Earthquake. Ms Margareta Wahlström, Special ...
(Date:5/20/2013)... Brenda Goodman HealthDay Reporter , , SATURDAY, May ... doctors a better view during colonoscopies may help them ... study shows. Colonoscopies are the recommended screening tests ... killer of men and women in the United States. ... flexible tube with a camera mounted on the end ...
(Date:5/20/2013)... with inflammatory bowel disease (IBD) are at higher risk ... at Mayo Clinic. Researchers found that IBD is associated ... The findings were presented at the Digestive Disease Week ... million Americans have Crohn,s disease or ulcerative colitis (UC), ... conditions inflame the lining of the intestine, leading to ...
(Date:5/20/2013)... 2013 ParentMagic, the creator of the best ... off the entire store in the month of May 2013. ... teachers, parents of adolescents and anyone interested in learning more ... books and other written materials, ParentMagic offers DVDs and Audio ... complement both the parent and teacher editions. , Parents who ...
Breaking Medicine News(10 mins):Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 2Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 3Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 4Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 5Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 6Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 7Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 8Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 9Health News:PolyU and Sichuan U Jointly Set Up China's First Institute for Disaster Management and Reconstruction 2Health News:PolyU and Sichuan U Jointly Set Up China's First Institute for Disaster Management and Reconstruction 3Health News:New Device May Show Doctors More of the Colon 2Health News:New Device May Show Doctors More of the Colon 3Health News:ParentMagic Announces May Sale, 20% Off Entire Catalog of Best Selling Books 2[0] Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S.[0] PolyU and Sichuan U Jointly Set Up China's First Institute for Disaster Management and Reconstruction[0] New Device May Show Doctors More of the Colon[0] Mayo Clinic: Inflammatory bowel disease raises risk of melanoma[0] ParentMagic Announces May Sale, 20% Off Entire Catalog of Best Selling Books
... factor, experts suggest, , , TUESDAY, April 15 (HealthDay News) ... dramatically after millions of American women stopped using hormone-replacement ... benefited black women. , In fact, the ... for black women from 2002 through 2004, while they ...
... Va., April 15, 2008 By combining the use ... at the University of Virginia have been able to ... cholangiocarcinoma, cancer of the liver bile duct. , Most ... surgery as it is diagnosed at such a late ...
... A CONTINUING SERIES OF PODCASTS FROM PEROT SYSTEMS ON THE IMPACT ... ... http://perotsystems.mediaroom.com/index.php?s=pageF , PLANO, TEXAS, April 15 Edition 18, ... International Healthcare, Guest: Dr. Elliot Sternberg, Chief Medical Officer for ...
... Inc.,(Amex: CUR ) today responds to an ... StemCells, Inc. has completely mischaracterized the meaning,of the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO ), "First," ... to,STEM,s statement, the numerous substantial amendments made by ...
... Survival programming, NEW YORK, April 15 Officials ... of the i,m Initiative by,announcing UNICEF,s designation as the ... netted $255,000 for the international,children,s organization., Twelve months ... D.C. as a way to connect its customers to ...
... Healthier blood,pressure. Less risk for diabetes and heart ... most adults. Here,s more on one popular food ... to this report from Apple Products Research and ... can access video, audio, text, graphics and,photos for ...
Cached Medicine News:Health News:Breast Cancer Unchanged in Black Women, Despite Drop in HRT Use 2Health News:Breast Cancer Unchanged in Black Women, Despite Drop in HRT Use 3Health News:Combining liver cancer treatments doubles survival rates, UVA researchers find 2Health News:HEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE' 2Health News:HEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE' 3Health News:Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents 2Health News:i'm Initiative Participants Select UNICEF as Top Charity in First Year of Microsoft's Initiative 2Breast Cancer Unchanged in Black Women, Despite Drop in HRT UseCombining liver cancer treatments doubles survival rates, UVA researchers findHEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE'Neuralstem Responds to Incorrect StemCells, Inc. Release on Patentsi'm Initiative Participants Select UNICEF as Top Charity in First Year of Microsoft's InitiativeAUDIO from Medialink and Apple Products Research and Education Council: New Research -- Adults Who Eat Apples, Apple Juice Have Healthier Diets and Lower Risk for Metabolic Syndrome
(Date:5/20/2013)... May 20, 2013 TNI BioTech, Inc. (OTCQB: TNIB), ... and mobilization of the body,s immune system using patented immunotherapy, ... Markets, OTCQB marketplace under the ticker symbol "TNIB" commencing ... real-time Level II stock quotes for TNIB at ... , CEO of TNI BioTech, Inc. stated, "We are ...
(Date:5/20/2013)... Medicare Part D seniors in plans with ... costs, convenient access to pharmacies and other benefits, ... Associates released today by the Pharmaceutical Care Management ... seniors (9.5 million) are currently enrolled in plans ... lower costs, pharmacy choices, and overall value of ...
(Date:5/20/2013)... 2013 With herbal medicines relied upon by ... U.S. Pharmacopeial Convention (USP) will provide freely available public ... ingredients used in these products. Today, USP proposes the ... Herbal Medicines Compendium ( HMC ) for ... hmc.usp.org . HMC will provide standards ...
Breaking Medicine Technology:TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3[0] TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace[0] Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices[0] New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines
... Data Showed Clinically Meaningful Benefits for Patients ... LONDON, May 29 ,GlaxoSmithKline (GSK) today announced ... the U.S. Food and Drug Administration and ... Rezonic(TM)/Zunrisa(TM) (casopitant), a novel,investigational NK-1 receptor antagonist. ...
... Phase III Studies With Ofatumumab, Zalutumumab and Zanolimumab, ... (OMX:,GEN) reports today that the last patient to ... in the pivotal Phase III clinical trial,of ofatumumab ... received the last scheduled treatment., In order ...
Cached Medicine Technology:GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 2GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 3GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 4GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 5GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 6GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 7GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 8Genmab Announces Updates on Phase III Cancer Studies 2Genmab Announces Updates on Phase III Cancer Studies 3... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |